There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Irisin has recently been introduced as a novel myokine which reverses visceral obesity
and improves glucose metabolism in mice. However, regulation of irisin in humans in
relation to renal and metabolic disease has not been comprehensively studied.